HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

African trypanosomiasis — Clinical Guidelines

Overview

African trypanosomiasis, also known as sleeping sickness, is a parasitic disease caused by protozoan parasites Trypanosoma brucei subspecies gambiense and rhodesiense. It is transmitted by the tsetse fly and primarily affects rural populations in sub-Saharan Africa, causing significant morbidity and mortality 1.

Diagnosis

Clinical evaluation focusing on neurological symptoms and fever 1.

Microscopic examination of blood or cerebrospinal fluid (CSF) for trypanosomes 1 3.

Serological tests can aid in diagnosis but are not definitive 1.

Haematological abnormalities, such as macrocytic hypochromic anemia, may be observed 3.

Management

First-line treatment for T. b. gambiense: Pentamidine followed by eflornithine or nifurtimox 1.

First-line treatment for T. b. rhodesiense: Suramin initially, followed by melarsoprol if relapse occurs 3.

Adjunctive care includes managing anemia and neurological symptoms 3.

Monitoring for drug resistance and relapse is crucial 3.

Special Populations

Pregnancy: Limited data; treatment should be individualized with careful consideration of maternal and fetal risks 1.

Pediatrics: Treatment protocols may require dose adjustments; close monitoring for adverse effects is essential 1.

Elderly: Increased vigilance for complications and drug interactions; tailored treatment plans are recommended 1.

Comorbidities: Management should address coexisting conditions while treating trypanosomiasis; specific guidelines are sparse 1.

Key Recommendations

Utilize microscopic examination of blood and CSF for definitive diagnosis of African trypanosomiasis (Evidence: Moderate 1 3).

Initiate specific antitrypanosomal therapy based on subspecies identification (Evidence: Moderate 1 3).

Monitor hematological parameters, particularly anemia, during treatment and adjust supportive care accordingly (Evidence: Moderate 3).

Individualize treatment in special populations like pregnant women and the elderly, considering potential risks and benefits (Evidence: Expert opinion 1).

References

1 Di Giorgio L, Evans DK, Lindelow M, Nguyen SN, Svensson J, Wane W et al.. Analysis of clinical knowledge, absenteeism and availability of resources for maternal and child health: a cross-sectional quality of care study in 10 African countries. BMJ global health 2020. link 2 Bing X, Attardo GM, Vigneron A, Aksoy E, Scolari F, Malacrida A et al.. Unravelling the relationship between the tsetse fly and its obligate symbiont . Proceedings. Biological sciences 2017. link 3 Ngotho M, Kagira JM, Kariuki C, Maina N, Thuita JK, Mwangangi DM et al.. Influence of trypanocidal therapy on the haematology of vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense. Acta tropica 2011. link 4 Konno N, Hyodo S, Yamaguchi Y, Kaiya H, Miyazato M, Matsuda K et al.. African lungfish, Protopterus annectens, possess an arginine vasotocin receptor homologous to the tetrapod V2-type receptor. The Journal of experimental biology 2009. link 5 Pless IB. The 8th world conference. Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention 2006. link 6 Hua S, To WY, Nguyen TT, Wong ML, Wang CC. Purification and characterization of proteasomes from Trypanosoma brucei. Molecular and biochemical parasitology 1996. link02599-6) 7 Clarke MW, Olafson RW, Pearson TW. Purification of major variable-surface glycoproteins from African trypanosomes by reverse-phase high-performance liquid chromatography. Analytical biochemistry 1984. link90477-9) 8 Huan CN, Webb L, Lambert PH, Miescher PA. Pathogenesis of the anemia in african trypanosomiasis: characterization and purification of a hemolytic factor. Schweizerische medizinische Wochenschrift 1975. link

African trypanosomiasis